Professional Documents
Culture Documents
EXPORT:
SQUARE started exporting finished pharmaceutical formulations since 1987. And it is the pioneer in
pharmaceutical export from Bangladesh.
SQUARE offers more than 200 molecules in over 400 formulations, from its 3 WHO GMP-compliant
manufacturing plants.
Future Focus:
Strengthen its position in the present markets
Work is in progress to enter into regulated markets in Europe and
United States
Work is in progress for the site approval by UK.
Current Export Market:
SL
Country Name
SL
Country Name
SL
Country Name
Cambodia
Pakistan
13
Ukraine
Vietnam
Ethiopia
14
Kosova
Myanmar
Russia
15
Yemen
Nigeria
10
Papua New
16
Kenya
Nepal
11
Sri Lanka
17
Guinea
South Africa
12
UK
The company has so far been able to enter into the markets of Russia, Pakistan, Sri Lanka,
Myanmar, Nepal, Combodia. It is expected that after the Dhaka Unit goes into production the
company will succeed in entering the markets of developed countries with expanded share of
exports.
GLOBAL PRESENCE
SQUARE has invested in state of the art formulation plants aligned to regulated market
standards. Six manufacturing units of the Dhaka site can produce pharmaceutical products
maintaining cGMP requirement for highly regulated markets in Europe, Australia and USA. Other
five manufacturing units at Pabna site are producing finished formulations targeting markets in
ASEAN, SAARC and marketing in RoW region. We have 700 product approvals for export
markets and 900 product approvals for Bangladesh market.
Present Markets
SQUARE Pharmaceuticals Ltd. is already supplying products to the following markets:
Europe: UK, Denmark, The Netherlands
Asia: Afghanistan, Bhutan, Cambodia, Fiji, Hong Kong, Iraq, Korea, Macau, Malaysia, Maldives,
Myanmar, Nepal, Papua New Guinea, Palau, Sri Lanka, Tajikistan, The Philippines, Uzbekistan,
Vietnam
Africa: Eritrea, Ivory Coast, Kenya, Libya, Malawi, Mauritania, Mauritius, Mozambique, Nigeria,
Somalia, Tanzania, Uganda
Central and South America: Belize, Costa Rica, Suriname
Highlights of the Export Operations
Exports pharmaceutical finished products since 1995
Offers quality products at competitive price
Offers more than 300 off-patent and on-patent molecules in different dosage forms
Offers facilities for contract manufacturing
Offers services for product development with subsequent technology transfer
Provides assistance in product promotion and training in overseas markets
SQUARE has latest technologies for production of a wide varieties of dosage forms including
Tablet, Sustained Release formulation, Capsule, Metered Dose Inhaler (MDI), Injectable, Syrup
(liquid and dry), Suspension (liquid and dry), Pediatric Drops, Nasal & Ophthalmic formulations,
Topical Gel/Ointment/Cream, and oral care formulations.
Current product mix of Square Pharmaceuticals Ltd. comprised of products from the following
Liquids
Topical solutions
Nasal drops
Dry powders
Topical
Analgesics/AntipyreticsAnthelmintics
AntiviralsBoneresorption preparations
Antiallergics
Dermatologicals
Antidepressants
Enzymes
Antidiabetics
Expectorants/Antitussives
Antidiarrheals
Hematinics
Antiemetics/Gastroprokinetics
Lipid modifiers/Antiobesity
Antifungal Systemic
Nootropics
Antigout
NSAIDs
Antihistaminics
Ophthalmic preparations
Antihypertensive / Antianginal
Sedatives/Tranquilizers/Muscle Relaxants
Antiinfectives/Antibacterial
Bronchodilators/Antiasthmatic
Antimalarial
Antiprotozoals
Androgen suppressants
Antiseptics/Disinfectants
Anti-migraine
Antispasmodics
Laxatives
Antiulcerants
Neurological